Close Menu
  • News
  • Entertainment
  • Sports
  • World
  • Health
  • Lifetsyle
  • contact

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Melania Trump details hands-on role in Ukraine ceasefire that evacuated nearly 800 civilians

November 20, 2026

UConn head coach Geno Auriemma not a fan of million dollar NIL payouts for incoming freshmen

November 20, 2026

Detroit Pistons to host Muslim Night with El-Sayed shoutout, Gaza donations; no Christian-focused event

November 20, 2026
Facebook X (Twitter) Instagram
Trending
  • Melania Trump details hands-on role in Ukraine ceasefire that evacuated nearly 800 civilians
  • UConn head coach Geno Auriemma not a fan of million dollar NIL payouts for incoming freshmen
  • Detroit Pistons to host Muslim Night with El-Sayed shoutout, Gaza donations; no Christian-focused event
  • Darius Rucker says he used to drink a bottle of whiskey a day during wild Hootie & the Blowfish years
  • MICHAEL RUIZ: Resurfaced video appears to show NYC mayor arrested by NYPD group he is disbanding
  • Suspect in alleged rape of LSU student killed by car fights to keep mom’s warning texts out of December trial
  • Woman allegedly torments California family claiming to be toddler who vanished in 1984, refuses basic DNA test
  • Fanatics Sportsbook Promo Code FOXNEWS: Claim $1000 in FanCash Betting on Tonight’s NBA Cup Slate
Facebook X (Twitter) Instagram
NEW YORK TIMES POST
  • News
  • Entertainment
  • Sports
  • World
  • Health
  • Lifetsyle
  • contact
NEW YORK TIMES POST
Home»Health»Targeted drug shrinks tumors in 3 out of 4 patients with advanced breast cancer
Health

Targeted drug shrinks tumors in 3 out of 4 patients with advanced breast cancer

nytimespostBy nytimespostOctober 29, 2026No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


NEWYou can now listen to Fox News articles!

There may be a promising new treatment on the horizon for advanced breast cancer patients, according to developing research.

Researchers are studying the cancer-killing drug trastuzmab rezetecan for those with ERBB2-low metastatic breast cancer, whose tumors have low levels of HER2, a protein that can help cancer cells grow.

A phase 3 clinical trial called HORIZON-Breast06 sought to determine whether the drug works better than standard chemotherapy for patients with this cancer type.

SHIFT IN CANCER SCREENING GUIDANCE HAS EXPERTS CLASHING OVER NEW GUIDANCE

The researchers analyzed 551 female patients across 73 hospitals in China who were randomly assigned to receive either the drug intravenously every three weeks, or the physician’s choice of chemotherapy. The study period lasted from June 2023 to August 2025.

oncologist hooking up a woman battling cancer to an IV

The median time without tumor growth on the drug was 16.4 months compared to 6.8 months with chemo. (iStock)

The drug significantly delayed cancer progression compared with chemotherapy, giving patients more than a year before their cancer began growing again.

The median time without tumor growth was 16.4 months compared to 6.8 months with chemo.

FDA APPROVES ONCE-DAILY PILL FOR DEADLY CANCER AFTER PATIENTS’ SURVIVAL RATES NEARLY DOUBLE

Patients who received trastuzumab rezetecan were 73% less likely to have their cancer worsen or die during the study than patients who received chemotherapy.

The drug appeared to delay cancer progression in patients with both hormone receptor-positive and hormone receptor-negative breast cancer.

The results were published in JAMA.

Cancer patient at doctor

The drug appeared to delay cancer progression in patients with both hormone receptor-positive and hormone receptor-negative breast cancer. (iStock)

Tumors shrank in 75.5% of patients who received the drug, compared with 41.2% of those who received chemotherapy.

At the 12-month mark, 90.6% of trastuzmab rezetecan patients were alive, compared to 81.4% of chemo patients.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The authors concluded that trastuzumab rezetecan provided “significant progression-free survival benefit over physician’s choice of chemotherapy in patients with ERBB2-low advanced breast cancer.”

Loren Rourke, a Texas-based breast surgical oncologist and author in Texas, called the results “incredibly encouraging.”

A cancer survivor smiles at a doctor in a doctor's office.

The researchers acknowledged that side effects occurred more frequently and “often required dose modification.” (iStock)

“When you’re talking about women living with advanced breast cancer, those months matter,” Rourke, who was not involved in the study, told Fox News Digital. “They represent more time when the cancer is being held in check and potentially more opportunities to enjoy life without the disease getting worse.”

What makes these findings especially exciting, according to the oncologist, is that the treatment showed benefits across different types of breast cancer.

CLICK HERE FOR MORE HEALTH STORIES

“It’s another important step forward, and it gives us genuine reason to be hopeful,” she said. “A treatment that can keep cancer from progressing for a longer period has the potential to make an enormous difference in a patient’s life.”

While the drug may cause fewer serious lung problems than similar treatments, it was linked to other side effects, including anemia and other blood-related problems.

“It’s another important step forward, and it gives us genuine reason to be hopeful.”

Serious side effects occurred in more than 84% of patients who received the new drug, compared with nearly 68% of those who received chemotherapy.

Rourke emphasized the importance of considering the side effects, “because more time without cancer progression doesn’t automatically mean better quality of life.”

Woman tired on couch

The researchers acknowledged that toxicity occurred more frequently and often required dose modification, although they said these effects were “generally manageable.” (iStock)

“We need to better understand the side effects, particularly the significant decreases in blood counts that can lead to fatigue, anemia and increased risk of infection,” she said.

The researchers acknowledged that toxicity occurred more frequently and often required dose modification, although they said these effects were “generally manageable.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The experts agreed that more research is needed.

“As exciting as these findings are, there are still important questions we need to answer,” Rourke told Fox News Digital. “We know this treatment delayed cancer progression, but we don’t yet know whether it will help patients live longer. That’s an important distinction.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“It’s important to celebrate meaningful progress while making sure we’re asking the right questions about what comes next.”

Angelica Stabile is a lifestyle reporter for Fox News Digital.

advanced breast breast cancer cancer cancer research drug health lifestyle medical research medications patients shrinks targeted tumors womens health
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

Related Posts

From panic rooms to private bowling alleys, Reddit reveals what only rich people have at home

November 20, 2026

Cheese aged in military fortress founded by Napoleon just named best in the world

November 20, 2026

Colombian president calls out 'false' New York Times report on US partnership against narcoterrorism

November 20, 2026
Leave A Reply Cancel Reply

The Latest News
  • Melania Trump details hands-on role in Ukraine ceasefire that evacuated nearly 800 civilians November 20, 2026
  • UConn head coach Geno Auriemma not a fan of million dollar NIL payouts for incoming freshmen November 20, 2026
  • Detroit Pistons to host Muslim Night with El-Sayed shoutout, Gaza donations; no Christian-focused event November 20, 2026
  • Darius Rucker says he used to drink a bottle of whiskey a day during wild Hootie & the Blowfish years November 20, 2026
  • MICHAEL RUIZ: Resurfaced video appears to show NYC mayor arrested by NYPD group he is disbanding November 20, 2026
  • Suspect in alleged rape of LSU student killed by car fights to keep mom’s warning texts out of December trial November 20, 2026
Top Posts

Melania Trump details hands-on role in Ukraine ceasefire that evacuated nearly 800 civilians

November 20, 2026

UConn head coach Geno Auriemma not a fan of million dollar NIL payouts for incoming freshmen

November 20, 2026

Detroit Pistons to host Muslim Night with El-Sayed shoutout, Gaza donations; no Christian-focused event

November 20, 2026

Darius Rucker says he used to drink a bottle of whiskey a day during wild Hootie & the Blowfish years

November 20, 2026
Don't Miss
Entertainment

Melania Trump details hands-on role in Ukraine ceasefire that evacuated nearly 800 civilians

By nytimespostNovember 20, 2026

NEWYou can now listen to Fox News articles! First lady Melania Trump offered a behind-the-scenes…

UConn head coach Geno Auriemma not a fan of million dollar NIL payouts for incoming freshmen

November 20, 2026

Detroit Pistons to host Muslim Night with El-Sayed shoutout, Gaza donations; no Christian-focused event

November 20, 2026

Darius Rucker says he used to drink a bottle of whiskey a day during wild Hootie & the Blowfish years

November 20, 2026
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo

Subscribe to Updates

Get the latest creative news from SmartMag about art & design.

NEW YORK TIMES POST

 

Categories
  • Business
  • Culture
  • Fashion
  • Food
  • Tech
  • Sports
  • Travel
  • Nature
Services
  • News
  • Entertainment
  • Sports
  • World
  • Health
  • Lifetsyle
  • contact
About Us

Email Us: info@nytimespost.com
Contact:

Facebook X (Twitter) Pinterest YouTube WhatsApp
Our Picks

Melania Trump details hands-on role in Ukraine ceasefire that evacuated nearly 800 civilians

November 20, 2026

UConn head coach Geno Auriemma not a fan of million dollar NIL payouts for incoming freshmen

November 20, 2026

Detroit Pistons to host Muslim Night with El-Sayed shoutout, Gaza donations; no Christian-focused event

November 20, 2026
Most Popular

Melania Trump details hands-on role in Ukraine ceasefire that evacuated nearly 800 civilians

November 20, 2026

UConn head coach Geno Auriemma not a fan of million dollar NIL payouts for incoming freshmen

November 20, 2026

Detroit Pistons to host Muslim Night with El-Sayed shoutout, Gaza donations; no Christian-focused event

November 20, 2026
© 2026 NY TIMES POST by NEW TORK TIMES POST.

Type above and press Enter to search. Press Esc to cancel.